MK

Mike Klein

North America, Michigan, United States, Ann Arbor

Description

Mike Klein is CEO at Genomenon, Inc.

Investor Profile

Mike Klein has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Developer Tools
  • Enterprise Software
  • Genetics
  • Medical
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mike Klein frequently co-invest with?

IrishAngels
North America, Illinois, United States, Chicago
Co-Investments: 1
Kaufman Financial Group
North America, Connecticut, United States, Farmington
Co-Investments: 1

What are some of recent deals done by Mike Klein?

Genomenon

Ann Arbor, Michigan, United States

Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making.

Developer ToolsEnterprise SoftwareGeneticsMedicalSoftware
SeedJan 8, 2019
Amount Raised: $2,477,201